ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0475

Whole-country and Regional Incidences of Giant Cell Arteritis in French Continental and Overseas Territories: A Nationwide Database Analysis

Hubert De Boysson1, Lydia GUITTET2, Damiano CERASUOLO2, Rémy MORELLO2, Samuel DESHAYES2 and Achille Aouba1, 1Department of Internal Medicine, UR4650 PSIR, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France, 2Caen University Hospital, Caen, France

Meeting: ACR Convergence 2022

Keywords: Disparities, Epidemiology, giant cell arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: The incidence rate of giant cell arteritis (GCA) is poorly studied in France. Therefore, we conducted a national hospital database study to assess the overall and regional incidence rates of GCA in France, including overseas territories.

Methods: Through the national hospitalization database of all patients hospitalized in France, new incidental GCA was identified using ICD-10 medical codes (M31.5 = GCA; M31.6 = GCA and polymyalgia rheumatica [PMR]) during 2013-2019. The regional incidences were analysed by graphical methods and Poisson regression.

Results: From 2013 to 2019, 16,540 patients were newly diagnosed with GCA+/- PMR through hospital recruitment in French territory, of which 16,436 were detected in continental France and 104 in overseas areas.

A mean of 2363 (range: 2170-2722) new GCA diagnoses were made each year in France. Sixty-five percent of cases were females. The age repartition was as follows: 5.2% of GCA patients were between 50 and 59 years old, 22.1% were between 60 and 69, 37.3% were between 70-79 and 35.5% were over 80.

Incidence rates did not significantly vary each year during the study period; however, the use of a temporal artery biopsy to diagnose GCA significantly decreased, from 61% in 2013 to 38% in 2019 (p< 0.0001).

The crude incidence rates of GCA+/-PMR per 100,000 persons aged ≥50 years were 9.64 [9.50—9.79] in continental France and 2.91 [2.35—3.47] in overseas areas. The crude incidence rate was 11.43 [11.21—11.65]) in females and 7.50 [7.31—7.70] in males (p< 0.0001). The incidence rate of GCA+/- PMR increased with age, from 50-54 to 80-85 years old in women and from 50-54 to 85-89 in men. It decreased in both sexes thereafter.

The detailed standard incident rates (SIRs) of GCA +/- PMR in the recently reformed 13 and 22 old continental French regions are shown in Table 1, Figure 1A and B. In overseas areas, the SIR of GCA+/- PMR was 3.45 [2.77–4.12].

At a departmental level (97 continental departments, Figure 1C), a gradient was noted with increasing SIRs from east to west (β= -0,016 [-0,023 – -0,009], p< 10-3). No significant north–south gradient was observed.

Conclusion: This French nationwide study provides new and dynamic insights regarding GCA +/- PMR incident rates at the country and regional levels. Important rate differences were observed between continental France and the overseas areas.

Supporting image 1

Table 1. Standardized incidence rates of GCA in the 13 main (in bold) and 22 historical (in italic) regions in continental France.

Supporting image 2

Figure 1. Standardized incident rates of GCA +/- PMR in the 13 new main regions (A), in the 22 former regions (B) and in the 97 continental (including Corsica) departments (C). Numbers on the Figure 1B refer to the French historical regions described in Table 1.


Disclosures: H. De Boysson, None; L. GUITTET, None; D. CERASUOLO, None; R. MORELLO, None; S. DESHAYES, None; A. Aouba, Roche.

To cite this abstract in AMA style:

De Boysson H, GUITTET L, CERASUOLO D, MORELLO R, DESHAYES S, Aouba A. Whole-country and Regional Incidences of Giant Cell Arteritis in French Continental and Overseas Territories: A Nationwide Database Analysis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/whole-country-and-regional-incidences-of-giant-cell-arteritis-in-french-continental-and-overseas-territories-a-nationwide-database-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/whole-country-and-regional-incidences-of-giant-cell-arteritis-in-french-continental-and-overseas-territories-a-nationwide-database-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology